Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

IMIPRAMINE HYDROCHLORIDE

IMIPRAMINE HYDROCHLORIDE

Standard Dose
25MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview IMIPRAMINE HYDROCHLORIDE is listed in Drugs@FDA under application 086765 (ANDA).

Marketing status: Discontinued Active ingredient IMIPRAMINE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - 25MG/ML Sponsor NOVARTIS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview IMIPRAMINE HYDROCHLORIDE is listed in Drugs@FDA under application 086765 (ANDA). Marketing status: Discontinued Active ingredient IMIPRAMINE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - 25MG/ML Sponsor NOVARTIS Submission history See approval history documents.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.